Mary R Lee

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date
    Mary R Lee
    Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Drug Abuse, 10 Center Drive, MSC 1108, Bethesda, MD, 20892 1108, USA
    CNS Drugs 30:109-23. 2016
  2. doi request reprint Complexity of oxytocin׳s effects in a chronic cocaine dependent population
    Mary R Lee
    National Institute on Alcohol Abuse and Alcoholism, Laboratory of Clinical and Translational Studies, Bethesda, MD, USA Electronic address
    Eur Neuropsychopharmacol 24:1483-91. 2014
  3. doi request reprint Gender differences in neural-behavioral response to self-observation during a novel fMRI social stress task
    Mary R Lee
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, United States Electronic address
    Neuropsychologia 53:257-63. 2014
  4. pmc A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback
    M R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse NIDA, Intramural Research Program, Baltimore, 21224, USA
    Genes Brain Behav 12:554-63. 2013
  5. pmc Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study
    Mary R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA
    Schizophr Res 145:110-5. 2013
  6. pmc Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans
    Mary R Lee
    National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, United States of America
    PLoS ONE 6:e24203. 2011
  7. doi request reprint Prefrontal white matter impairment in substance users depends upon the catechol-o-methyl transferase (COMT) val158met polymorphism
    Xiaochu Zhang
    Neuroimaging Research Branch, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Neuroimage 69:62-9. 2013
  8. doi request reprint Effect of Functionally Significant Deiodinase Single Nucleotide Polymorphisms on Drinking Behavior in Alcohol Dependence: An Exploratory Investigation
    Mary R Lee
    Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland
    Alcohol Clin Exp Res 39:1665-70. 2015
  9. pmc Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat
    Thomas C Jhou
    Behavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA
    Psychopharmacology (Berl) 224:303-12. 2012
  10. doi request reprint Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date
    Mary R Lee
    Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive 10CRC 15330 MSC 1108, Room 1 5429, Bethesda, MD, 20892 1108, USA
    CNS Drugs 28:107-19. 2014

Detail Information

Publications11

  1. doi request reprint Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date
    Mary R Lee
    Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Drug Abuse, 10 Center Drive, MSC 1108, Bethesda, MD, 20892 1108, USA
    CNS Drugs 30:109-23. 2016
    ..This review summarizes the preclinical as well as clinical literature to date on the oxytocin system and its relevance to drug and alcohol addiction. ..
  2. doi request reprint Complexity of oxytocin׳s effects in a chronic cocaine dependent population
    Mary R Lee
    National Institute on Alcohol Abuse and Alcoholism, Laboratory of Clinical and Translational Studies, Bethesda, MD, USA Electronic address
    Eur Neuropsychopharmacol 24:1483-91. 2014
    ..These findings are discussed in light of the human and rodent oxytocin literature. ..
  3. doi request reprint Gender differences in neural-behavioral response to self-observation during a novel fMRI social stress task
    Mary R Lee
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, United States Electronic address
    Neuropsychologia 53:257-63. 2014
    ..During fMRI scanning, subjects were shown alternating video clips of two..
  4. pmc A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback
    M R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse NIDA, Intramural Research Program, Baltimore, 21224, USA
    Genes Brain Behav 12:554-63. 2013
    ....
  5. pmc Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study
    Mary R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA
    Schizophr Res 145:110-5. 2013
    ....
  6. pmc Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans
    Mary R Lee
    National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, United States of America
    PLoS ONE 6:e24203. 2011
    ....
  7. doi request reprint Prefrontal white matter impairment in substance users depends upon the catechol-o-methyl transferase (COMT) val158met polymorphism
    Xiaochu Zhang
    Neuroimaging Research Branch, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Neuroimage 69:62-9. 2013
    ....
  8. doi request reprint Effect of Functionally Significant Deiodinase Single Nucleotide Polymorphisms on Drinking Behavior in Alcohol Dependence: An Exploratory Investigation
    Mary R Lee
    Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland
    Alcohol Clin Exp Res 39:1665-70. 2015
    ..In the context of alcohol use, functionally significant single nucleotide polymorphisms (SNPs) of these deiodinase genes may play a role in HPT dysfunction...
  9. pmc Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat
    Thomas C Jhou
    Behavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA
    Psychopharmacology (Berl) 224:303-12. 2012
    ....
  10. doi request reprint Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date
    Mary R Lee
    Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 10 Center Drive 10CRC 15330 MSC 1108, Room 1 5429, Bethesda, MD, 20892 1108, USA
    CNS Drugs 28:107-19. 2014
    ..Limitations of the current published studies and possible future directions for new combinations are discussed...
  11. doi request reprint Addiction and corticotropin-releasing hormone type 1 receptor antagonist medications
    Carlo Contoreggi
    Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Ann N Y Acad Sci 1282:107-18. 2013
    ..Investigators designing future trials might refocus their understanding of addiction and treatment in this new direction...